Laursen Van Swieten

PropTexx is a prominent global real estate technology company that specializes in artificial intelligence solutions tailored for the real estate sector. The company focuses on enhancing the quality and representation of online property listings through a suite of tech-driven products and processes. Its platform incorporates advanced features such as automated creation of real estate listings, generation of engaging descriptions, pre-population of listings, virtual staging, and image tagging. These capabilities, developed using proprietary algorithms by a dedicated team, enable real estate professionals to streamline their operations and effectively engage potential buyers.

PropTexx is a prominent global real estate technology company that specializes in artificial intelligence solutions tailored for the real estate sector. The company focuses on enhancing the quality and representation of online property listings through a suite of tech-driven products and processes. Its platform incorporates advanced features such as automated creation of real estate listings, generation of engaging descriptions, pre-population of listings, virtual staging, and image tagging. These capabilities, developed using proprietary algorithms by a dedicated team, enable real estate professionals to streamline their operations and effectively engage potential buyers.

Silenseed Ltd. is a biopharmaceutical company headquartered in Jerusalem, Israel, specializing in the discovery and development of RNA interference (RNAi)-based cancer therapeutics and innovative delivery systems. The company aims to address malignant solid tumors by leveraging its proprietary LODER delivery platform, which enhances the efficacy of its drug formulations. Silenseed’s lead product, SiG12D-LODER, has progressed through pre-clinical studies and an open label Phase I clinical trial for pancreatic cancer. Additionally, the company is developing Prostate-LODER for prostate cancer and GBM-LODER targeting Glioblastoma Multiforme, both of which are currently in pre-clinical studies. Founded in 2008, Silenseed is positioned at the forefront of cancer treatment advancements with its focus on localized drug delivery to improve therapeutic outcomes for patients.

Soltaro is a developer of solar battery storage solutions focused on enhancing energy efficiency. The company specializes in lithium-ion phosphate batteries, which are designed to provide hybrid battery systems or AC retrofits for existing solar installations. By enabling the storage of solar power generated from photovoltaic systems, Soltaro's products help customers reduce their energy consumption and lower their electricity bills by allowing them to store and utilize unused electricity.